The Foundation for Development of the Centre of Research and Commercializing of New Technologies — Skolkovo Foundation
Participating in the development of:
In August 2011 LLC IBC Generium received a resident status in the “Skolkovo Foundation”. This allowed our company to receive a number of tax and customs preferences, as well as the ability to use the infrastructure of the “Skolkovo” Technopark within the Skolkovo Innovation Center.
In March of 2012 our company is planing to submit a package of documents to obtain a grant support for the development of innovative drugs for treatment of B-cell lymphomas.